The COMPUS Expert Review Committee (CERC) is appointed by and reports to the Canadian Agency for Drugs and Technologies in Health (CADTH) Board of Directors. CERC is an advisory body that makes recommendations related to the identification, evaluation, and promotion of optimal drug prescribing and use in Canada.
The CERC Nominating Committee is seeking nominations to fill one Core Member (expert) position with an individual who is qualified as a physician (general practitioner).
If you know of someone who has the qualifications we seek, we invite you to submit a nomination. Nomination packages and instructions can be found on the CADTH website.
Federal, provincial, and territorial jurisdictions; relevant health professional bodies; individual health and other professionals; the general public; and the CERC Nominating Committee are eligible to nominate CERC members.
If you have any questions about the nomination process, please visit the CADTH website or contact Denis Bélanger at denisb@cadth.ca or 613-226-2553. Nomination packages must be submitted to the COMPUS Directorate (through Denis Bélanger) by Thursday, March 26, 2009.
Today, COMPUS released the following report from its series of Optimal Therapy Reports on the prescribing and use of blood glucose test strips:
Current Utilization of Blood Glucose Test Strips in Canada
The purpose of this report is to examine how blood glucose test strips are currently used in Canada in the self-monitoring of blood glucose by patients with diabetes.
COMPUS/RxFiles
Pearls Document
This document provides objective, detailed evidence and messaging “Pearls” to help front-line practitioners provide the optimal drug therapy when considering insulin use in patients with diabetes. This intervention tool was adapted for COMPUS by Rx Files.
CADTH is seeking candidates for a variety of positions that are posted on the Careers page.
We welcome your feedback. Tell us what you think of the COMPUS Communiqué.